https://www.selleckchem.com/
d predict disease progression and measure therapeutic effectiveness in the future clinical trials. Patients with dementia are vulnerable during the coronavirus disease 2019 (COVID-19) pandemic, yet few studies describe their hospital course and outcomes. To describe and compare the hospital course for COVID-19 patients with dementia to an aging cohort without dementia in a large New York City academic medical center. This was a single-center retrospective cohort study describing all consecutive patients age 65 or older with confirmed COVID-19 who presented
Like
Comment
Share
